Janet L Gunzner-Toste

USPTO Granted Patents = 11 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 9.7

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Piedmont, CA (US) (2013 - 2017)
Berkeley, CA (US) (2018 - 2020)
South San Francisco, CA (US) (2020 - 2023)

Company Filing History:

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11692043 - Peptidomimetic compounds and antibody-drug conjugates thereof (2023-07-04),

2. 11135303 - Pyrrolobenzodiazepines and conjugates thereof (2021-10-05),

3. 10696692 - Amido-benzyl sulfone and sulfoxide derivates (2020-06-30),

4. 10632210 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-04-28),

5. 10533058 - Peptidomimetic compounds and antibody-drug conjugates thereof (2020-01-14),

6. 10124069 - Peptidomimetic compounds and antibody-drug conjugates thereof (2018-11-13),

7. 9999681 - Peptidomimetic compounds and antibody-drug conjugates thereof (2018-06-19),

8. 9790183 - Pyridyl inhibitors of hedgehog signalling (2017-10-17),

9. 9321761 - Pyridyl inhibitors of hedgehog signalling (2016-04-26),

10. 8809331 - Aminopyrimidine derivatives as LRRK2 modulators (2014-08-19),

11. 8354420 - Aminopyrimidine derivatives as LRRK2 inhibitors (2013-01-15),

Title: Janet L Gunzner-Toste: Innovator in Cancer Therapy

Introduction

Janet L Gunzner-Toste is a prominent inventor based in Piedmont, CA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative therapies for cancer treatment. With a total of 11 patents to her name, her work has had a profound impact on medical research and drug development.

Latest Patents

Among her latest patents are two notable inventions. The first is related to peptidomimetic compounds and antibody-drug conjugates. This invention focuses on peptidomimetic linkers and the pharmaceutical compositions containing them, which are utilized in therapies aimed at preventing and treating cancer. The second patent involves pyrrolobenzodiazepines and their conjugates, detailing a specific conjugate formula that enhances the efficacy of cancer treatments.

Career Highlights

Throughout her career, Janet has worked with leading companies in the biotechnology sector, including Genentech, Inc. and MedImmune Limited. Her expertise and innovative approach have positioned her as a key player in the development of new therapeutic strategies.

Collaborations

Janet has collaborated with esteemed colleagues in her field, including Guiling Zhao and John A Flygare. These partnerships have further enriched her research and contributed to the advancement of cancer therapies.

Conclusion

Janet L Gunzner-Toste's contributions to cancer therapy through her innovative patents and collaborations highlight her significant role in the field of pharmaceutical sciences. Her work continues to inspire advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.